Spoločnosť Glycanostics získala prestížny grant Európskej rady pre inovácie EIC Accelerator
Spoločnosť Glycanostics bola zaradená do užšieho zoznamu 65 inovatívnych startupov, malých a stredných podnikov spomedzi viac než 4 000 žiadateľov o finančný grant v rámci schémy Európskej rady pre inovácie EIC Accelerator. Glycanostics je tak
Spoločnosť Glycanostics zožala úspech na investičnej platforme Crowdberry
Tím spoločnosti Glycanostics dosiahol ďalší dôležitý míľnik! Prostredníctvom investičnej platformy Crowdberry sme v septembri 2021 prezentovali investorom náš mimoriadne presný diagnostický test a podarilo sa nám získať ďalšiu investíciu vo výške 690
Zástupcovia spoločnosti Glycanostics na stretnutí s predsedníčkou Európskej komisie, Ursulou von der Leyenovou
V pondelok 21. júna mala naša CEO Eva Kováčová (na obrázku vpravo) a náš CSO Ján Tkáč (vľavo) veľkú česť predstaviť spoločnosť Glycanostics za prítomnosti predsedníčky Európskej komisie Ursuly von der
Dôležitý krok pre spoločnosť Glycanostics v spolupráci s Crowdberry Investment Management (CBIM)
Glycanostics a Crowdberry Investment Management podnikli dôležitý krok k dosiahnutiu vízie našej spoločnosti. V piatok 7. mája 2021 sme podpísali investičnú dohodu, na základe ktorej získa Glycanostics kľúčové finančné zdroje vo výške
A HIGHLY-PRESTIGIOUS AWARD FOR A GLYCANOSTICS CO-FOUNDER
This year, a well-established IT company from Slovakia ESET launched a prestigious ESET Science Award for exceptional scientists to increase the popularity of excellent scientists. Among all the scientists nominated,
INTERNATIONAL PATENT APPLICATION NO. PCT/EP2019/057386
On 3rdOctober 2019, PCT application titled “Means and methods for glycoprofiling of aprotein” (applicant Glycanostics, inventors Tomas Bertok and Jan Tkac) waspublished under publication number WO 2019/185515. This patent applicationcovers the
GLYCANOSTICS WINS NATIONAL ROUND OF CENTRAL EUROPEAN STARTUP AWARDS
With the unique, glycan-based technology and possible benefits forpatients, clinicians and society, Glycanostics was announced as a CESA awardwinner in two independent categories – Best Health-Tech Startup and Best SocialImpact
GLYCANOSTICS WINS HORIZON 2020 GRANT
After receiving the prestigious “Seal of Excellence” from the European Commission on October 23, 2018, Glycanostics‘ next submission, to the Horizon 2020 Programme, won a € 50 000 grant. The Horizon 2020 Programme
GLYCANOSTICS RECEIVES THE PRESTIGIOUS HORIZON 2020 “SEAL OF EXCELLENCE”
The European Commission awarded Glycanostics the prestigious Seal of Excellence for its revolutionary prostate cancer early diagnostic tests. This project was submitted under the Horizon 2020 Programme for Research and Innovation 2014-2020,
GLYCANOSTICS WINS TOP-6 BEST STARTUPS IN CENTRAL EUROPE
The FutureNow startup competition, also known as the Startup Awards, is akin to the Oscars for the best startups with global potential. This year marked the eighth and largest occurrence
GLYCANOSTICS SUCCESFULLY FINISHED HORIZON 2020 SME INSTRUMENT 1 GRANT
In august 2019, Glycanostics successfully finished the first phase of SME Instrument, by finishing a feasibility study and a business plan with the help from advisors and a consultation agency.
GLYCANOSTICS WINS THE EUROPEAN RESEARCH COUNCIL GRANT
Glycanostics innovations are again supported and highly ranked by leading industry experts. This time the company won the European Research Council (ERC) Proof of Concept Grant. The ERC president Jean Pierre
